TrialScientific reports2018

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Yi-Yuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.